Today: 30 April 2026
Amphenol stock jumps 4% after JPMorgan lifts target ahead of Q4 earnings
27 January 2026
1 min read

Amphenol stock jumps 4% after JPMorgan lifts target ahead of Q4 earnings

New York, January 27, 2026, 13:19 EST — Regular session

  • Shares of Amphenol climbed 4.1%, reaching $161.96 in early afternoon trading
  • JPMorgan raised its price target to $185 from $160, maintaining its Overweight rating
  • Amphenol’s Q4 results, due Wednesday, are drawing investor attention

Shares of Amphenol Corp jumped roughly 4% Tuesday following a price target boost from JPMorgan ahead of the company’s quarterly earnings. The stock hit an intraday peak above $163 on the move.

Amphenol’s upcoming fourth-quarter results, due Wednesday, are drawing attention as investors seek updated figures on demand from cloud data centers and other electronics sectors. The company’s investor calendar lists its earnings call for Jan. 28 at 1 p.m. ET.

JPMorgan boosted its price target on Amphenol to $185 from $160, maintaining an Overweight rating. This move could influence near-term sentiment, even if it’s not a direct trading signal. The bank highlighted the recent CCS acquisition, saying it expands Amphenol’s reach within the optical “total addressable market”—a term analysts use for potential demand—and taps into IT and datacom spending by hyperscalers, the largest cloud operators. Investing.com

On Jan. 12, Amphenol announced it has finalized the acquisition of CommScope’s Connectivity and Cable Solutions business, boosting its Communications Solutions segment with fiber-optic and industrial interconnect products. CEO R. Adam Norwitt highlighted that the CCS deal “adds significant fiber optic interconnect capabilities” tailored for IT datacom and communications networks. The company projects the CCS unit will bring in roughly $4.1 billion in sales by 2026 and expects it to contribute about $0.15 per share to 2026 diluted EPS, excluding costs tied to the acquisition. investors.amphenol.com

Amphenol’s earnings expectations aren’t modest. Back in October, the company projected Q4 sales between $6.0 billion and $6.1 billion, with adjusted diluted EPS in the $0.89 to $0.91 range—figures signaling robust year-over-year growth.

Tuesday’s jump built on Monday’s rally. Amphenol ended Monday at $155.56, roughly 3% higher, edging near a recent peak before pushing even higher on Tuesday.

That setup works both ways. Should margins fall short or if management signals caution on 2026 orders following a major acquisition, traders could pull back fast from any pre-earnings rally — particularly in a stock that’s already seen a steep repricing.

Investors will be zeroed in on one thing Wednesday: if Amphenol hits its fourth-quarter targets and offers a clearer picture of growth and profit for 2026 now that CCS is part of the mix.

Stock Market Today

  • KalVista Pharmaceuticals Rises 39% on Acquisition Deal with Chiesi Group
    April 29, 2026, 6:37 PM EDT. KalVista Pharmaceuticals surged 38.62% to $26.67 after announcing its acquisition by Italy's Chiesi Group at $27 per share in cash. The deal sparked high trading volume, reaching 69.4 million shares, over 3,000% above average. KalVista, known for its oral therapy EKTERLY for hereditary angioedema, could benefit from Chiesi's global reach. The broader market was mixed: the S&P 500 dipped 0.02% to 7,138, while the Nasdaq edged up 0.04% to 24,673. Rival biotech stock Prothena dropped 5.56% amid investor caution over drug pipelines. KalVista's acquisition marks a shift for a company that faced heavy short interest and revenue challenges, positioning it for growth under Chiesi's ownership, pending regulatory approval.

Latest article

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
Markel Stock Slides After $728 Million Investment Loss Masks Insurance Turnaround

Markel Stock Slides After $728 Million Investment Loss Masks Insurance Turnaround

30 April 2026
Markel Group posted a $212.3 million net loss for the first quarter, driven by a $728 million investment loss, sending shares down 7.9% to $1,759.21. Operating revenue held steady at $3.55 billion, while adjusted operating income rose 4% to $498 million. Markel Insurance’s adjusted operating income jumped 31% to $369 million. Gross premium volume in underwriting fell 21% after exiting Global Reinsurance.
QQQ Rises Today as Big Tech Earnings Put the Nasdaq 100 Rally on the Line

QQQ Rises Today as Big Tech Earnings Put the Nasdaq 100 Rally on the Line

30 April 2026
The Invesco QQQ Trust closed up $3.99 at $661.57 Wednesday as investors positioned ahead of earnings from Microsoft, Alphabet, Amazon, and Meta. Volume topped 30 million shares. Microsoft and Alphabet reported strong cloud and AI-driven revenue growth after the bell. The broader Nasdaq Composite edged up 0.04%, while the S&P 500 slipped 0.04%.
Lumen Technologies (LUMN) stock jumps on ISO 42001 AI certification as earnings loom
Previous Story

Lumen Technologies (LUMN) stock jumps on ISO 42001 AI certification as earnings loom

Caterpillar stock rises after Jefferies lifts CAT target to $750, with earnings next
Next Story

Caterpillar stock rises after Jefferies lifts CAT target to $750, with earnings next

Go toTop